aPKC-iota promotes gallbaldder cancer tumorigenesis and gemcitabine-resistant by competing with Nrf2 for binding to Keap1

aPKC-iota promotes gallbaldder cancer tumorigenesis and gemcitabine-resistant by competing with Nrf2 for binding to Keap1
复制标题

aPKC-iota 通过与 Nrf2 竞争与 Keap1 的结合来促进胆囊癌肿瘤发生和吉西他滨耐药

DOI:
--
复制
发表时间:
2019
期刊:
影响因子:
11.4
通讯作者:
Jianming Wang
Jianming Wang
中科院分区:
生物学1区
文献类型:
--
作者:
Li Tian;Yun Lu;Tao Yang;Zhengdong Deng;Lei Xu;Wei Yao;Chaoqun Ma;Xiangyu Li;Jian Zhang;Yan Liu;Jianming Wang

文献摘要

相似文献